X Logo (EUIPO, 11/25/2016)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark X was filed as Figurative mark on 11/25/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/19/2017.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Triangles or lines forming an angle with one or more quadrilaterals
| Trademark form | Figurative mark |
| File reference | 016088312 |
| Application date | November 25, 2016 |
| Publication date | March 10, 2017 |
| Entry date | June 19, 2017 |
| Expiration date | November 25, 2026 |
Trademark owner
840 Memorial Drive, Third Floor
02139 Cambridge
US
02139 Cambridge
US
Trademark representatives
Salierring 47 - 53
50677 Köln
DE
goods and services
1
Chemical substances, chemical materials and chemical preparations, and natural elements; biochemical preparations for scientific purposes; chemical and organic compositions for use in the manufacture of food and beverages; proteins, polypeptides, peptides and amino acids for use in scientific and medical research; reagents for scientific or medical research use, namely small molecules for use in scientific and medical research; nutrients and nutritive products, namely, proteins, polypeptides, peptides and amino acids for use in the manufacture of beverages, food products and food supplements for human and non-human use; chemical and organic compositions for use in the manufacture of food and beverages, namely nutrients and nutritive products, namely small molecules for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins, polypeptides, peptides and amino acids for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; chemical substances for use in the manufacture, namely small molecules for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research; proteins, polypeptides, peptides, amino acids being a featured component of pharmaceutical preparations
5
Pharmaceutical preparations and substances; medical preparations; dietary supplements and dietetic preparations; nutritional supplements; pharmaceutical preparations and substances for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction; pharmaceutical preparations and substances for the treatment of the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids for pharmaceutical use; pharmaceutical substances, namely small molecules being a featured component of pharmaceutical preparations; medicines; medical foods; nutraceuticals; dietary and nutritional supplements
42
Research and development services; research and development of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; characterization of metrics and biomarkers, namely, development and evaluation of assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction; characterization of metrics and biomarkers, namely, development and evaluation of assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment of the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system; characterization of metrics and biomarkers, namely, development and evaluation of assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment of the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement
ID: 11016088312